Facebook
Twitter
Telegram
Report an ErrorElanco Animal Health Incorporated Balance Sheet 2011-2024 | ELAN
Annual Balance Sheet Elanco Animal Health Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
5.42 B | 5.13 B | 5.42 B | 85 M | 2.02 B | 2 B | -323 M | -259 M | - | - | - | - | - |
Long Term Debt |
5.74 B | 5.45 B | 6.02 B | 554 M | 2.33 B | 2.44 B | - | - | - | - | - | - | - |
Long Term Debt Current |
32 M | 31 M | 34 M | 37 M | 23.7 M | 29 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 2.62 B | 2.79 B | 517 M | 453 M | - | - | - | - | - |
Total Current Liabilities |
1.24 B | 1.7 B | 1.65 B | 2.08 B | 818 M | 971 M | - | - | - | - | - | - | - |
Total Liabilities |
8.14 B | 8.2 B | 8.97 B | 9.22 B | 3.44 B | 3.76 B | 1.15 B | 1.07 B | - | - | - | - | - |
Deferred Revenue |
367 M | 324 M | 319 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.29 B | -1.06 B | -979 M | -477 M | 84.3 M | 16.4 M | - | - | - | - | - | - | - |
Total Assets |
14.4 B | 15.5 B | 16.5 B | 17.7 B | 8.99 B | 8.96 B | 8.94 B | 8.1 B | - | - | - | - | - |
Cash and Cash Equivalents |
352 M | 345 M | 638 M | 506 M | 334 M | 475 M | 323 M | 259 M | - | - | - | - | - |
Book Value |
6.22 B | 7.29 B | 7.51 B | 8.48 B | 5.55 B | 5.2 B | 7.79 B | 7.03 B | - | - | - | - | - |
Total Shareholders Equity |
6.22 B | 7.29 B | 7.51 B | 8.46 B | 5.55 B | 5.2 B | 7.78 B | 7.02 B | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Elanco Animal Health Incorporated
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
5.73 B | 5.74 B | 5.87 B | 6.02 B | 5.64 B | 5.45 B | 5.51 B | 6.01 B | 6.07 B | 6.02 B | 6.27 B | 5.54 B | 5.56 B | 5.57 B | 5.57 B | 5.57 B | 5.57 B | 2.33 B | 2.33 B | 2.33 B | 2.33 B | 2.44 B | 2.44 B | 2.44 B | 2.44 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
7.96 B | 8.14 B | 8.21 B | 8.38 B | 8.29 B | 8.2 B | 8.2 B | 8.46 B | 8.64 B | 8.94 B | 8.88 B | 8.85 B | 8.98 B | 9.22 B | 9.22 B | 9.22 B | 9.22 B | 3.44 B | 3.44 B | 3.44 B | 3.44 B | 3.76 B | 3.76 B | 3.76 B | 3.76 B | 1.16 B | 1.16 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
318 M | 367 M | 356 M | 332 M | 329 M | 324 M | 298 M | 284 M | 295 M | 316 M | 316 M | 303 M | 331 M | 295 M | 295 M | 295 M | 295 M | 211 M | 211 M | 211 M | 211 M | 170 M | 170 M | 170 M | 170 M | 166 M | 166 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.26 B | -2.29 B | -2.15 B | -1.05 B | -954 M | -1.06 B | -972 M | -923 M | -901 M | -949 M | -852 M | -748 M | -538 M | -477 M | -477 M | -477 M | -477 M | 84.3 M | 84.3 M | 84.3 M | 84.3 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
14 B | 14.4 B | 14.3 B | 15.8 B | 15.8 B | 15.5 B | 14.9 B | 15.6 B | 16.3 B | 16.5 B | 16.6 B | 16.8 B | 17 B | 17.7 B | 17.7 B | 17.7 B | 17.7 B | 8.99 B | 8.99 B | 8.99 B | 8.99 B | 8.96 B | 8.96 B | 8.96 B | 8.96 B | 8.94 B | 8.94 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
345 M | 352 M | 369 M | 367 M | 318 M | 345 M | 460 M | 507 M | 342 M | 638 M | 453 M | 580 M | 515 M | 506 M | 495 M | 495 M | 495 M | 334 M | 334 M | 334 M | 334 M | 475 M | 475 M | 475 M | 475 M | 323 M | 323 M | - | - | 259 M | - | - | - | 461 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
6.06 B | 6.22 B | 6.13 B | 7.42 B | 7.48 B | 7.29 B | 6.74 B | 7.14 B | 7.61 B | 7.54 B | 7.68 B | 7.98 B | 8.01 B | 8.48 B | 8.48 B | 8.48 B | 8.48 B | 5.55 B | 5.55 B | 5.55 B | 5.55 B | 5.2 B | 5.2 B | 5.2 B | 5.2 B | 7.78 B | 7.78 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
6.06 B | 6.22 B | 6.13 B | 7.42 B | 7.48 B | 7.29 B | 6.71 B | 7.12 B | 7.58 B | 7.54 B | 7.68 B | 7.98 B | 8.01 B | 8.48 B | 8.48 B | 8.48 B | 8.48 B | 5.55 B | 5.55 B | 5.55 B | 5.55 B | 5.2 B | 5.2 B | 5.2 B | 5.2 B | 7.78 B | 7.78 B | - | - | 7.02 B | - | - | - | 7.43 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency